Myoid gonadal stromal tumor

a clinicopathologic study of three cases of a distinctive testicular tumor

Chia Sui Kao, Thomas Ulbright

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

OBJECTIVES: To report three new cases of testicular myoid gonadal stromal tumor to better characterize its features.

METHODS: The clinicopathologic findings (including follow-up) were evaluated and a review of the literature was performed.

RESULTS: The patients were 38, 43, and 59 years old, and tumor sizes were 1.2, 1.3, and 3.2 cm. All were unilateral, well circumscribed, adjacent to the rete testis, and composed exclusively of spindled cells with elongated nuclei and occasional nuclear grooves arranged in fascicles with admixed variably ectatic blood vessels. Nucleoli were inconspicuous, and the cytoplasm was scant, ill-defined, and pale/lightly eosinophilic. No sex cord component was present. Mitotic figures ranged from zero to five per 10 high-power fields. Significant atypia, lymphovascular invasion, and necrosis were absent. All were consistently positive for smooth muscle actin, S100 protein, FOXL2, and steroidogenic factor 1 but negative for h-caldesmon, calretinin, and SOX9. Inhibin and calponin were focally positive. All patients were alive and well at 5, 31, and 58 months postorchiectomy. Combining our cases with those previously reported (n = 6) shows that this neoplasm occurs mostly in younger men (mean, 37 years), and all follow-up thus far (mean, 25 months) has been benign.

CONCLUSIONS: Myoid gonadal stromal tumors are small (<4 cm) indolent testicular tumors distinctly different from other sex cord-stromal tumors and are adequately managed by orchiectomy.

Original languageEnglish
Pages (from-to)675-682
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume142
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

Testicular Neoplasms
Neoplasms
Sex Cord-Gonadal Stromal Tumors
Steroidogenic Factor 1
Rete Testis
Calmodulin-Binding Proteins
Calbindin 2
Inhibins
Orchiectomy
S100 Proteins
Smooth Muscle
Blood Vessels
Actins
Cytoplasm
Necrosis

Keywords

  • Immunohistochemistry
  • Myoid gonadal stromal tumor
  • Testis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Myoid gonadal stromal tumor : a clinicopathologic study of three cases of a distinctive testicular tumor. / Kao, Chia Sui; Ulbright, Thomas.

In: American Journal of Clinical Pathology, Vol. 142, No. 5, 01.11.2014, p. 675-682.

Research output: Contribution to journalArticle

@article{c5d18282a6414c8d907027f46c290d47,
title = "Myoid gonadal stromal tumor: a clinicopathologic study of three cases of a distinctive testicular tumor",
abstract = "OBJECTIVES: To report three new cases of testicular myoid gonadal stromal tumor to better characterize its features.METHODS: The clinicopathologic findings (including follow-up) were evaluated and a review of the literature was performed.RESULTS: The patients were 38, 43, and 59 years old, and tumor sizes were 1.2, 1.3, and 3.2 cm. All were unilateral, well circumscribed, adjacent to the rete testis, and composed exclusively of spindled cells with elongated nuclei and occasional nuclear grooves arranged in fascicles with admixed variably ectatic blood vessels. Nucleoli were inconspicuous, and the cytoplasm was scant, ill-defined, and pale/lightly eosinophilic. No sex cord component was present. Mitotic figures ranged from zero to five per 10 high-power fields. Significant atypia, lymphovascular invasion, and necrosis were absent. All were consistently positive for smooth muscle actin, S100 protein, FOXL2, and steroidogenic factor 1 but negative for h-caldesmon, calretinin, and SOX9. Inhibin and calponin were focally positive. All patients were alive and well at 5, 31, and 58 months postorchiectomy. Combining our cases with those previously reported (n = 6) shows that this neoplasm occurs mostly in younger men (mean, 37 years), and all follow-up thus far (mean, 25 months) has been benign.CONCLUSIONS: Myoid gonadal stromal tumors are small (<4 cm) indolent testicular tumors distinctly different from other sex cord-stromal tumors and are adequately managed by orchiectomy.",
keywords = "Immunohistochemistry, Myoid gonadal stromal tumor, Testis",
author = "Kao, {Chia Sui} and Thomas Ulbright",
year = "2014",
month = "11",
day = "1",
doi = "10.1309/AJCPGSCD1DGNZ0QO",
language = "English",
volume = "142",
pages = "675--682",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - Myoid gonadal stromal tumor

T2 - a clinicopathologic study of three cases of a distinctive testicular tumor

AU - Kao, Chia Sui

AU - Ulbright, Thomas

PY - 2014/11/1

Y1 - 2014/11/1

N2 - OBJECTIVES: To report three new cases of testicular myoid gonadal stromal tumor to better characterize its features.METHODS: The clinicopathologic findings (including follow-up) were evaluated and a review of the literature was performed.RESULTS: The patients were 38, 43, and 59 years old, and tumor sizes were 1.2, 1.3, and 3.2 cm. All were unilateral, well circumscribed, adjacent to the rete testis, and composed exclusively of spindled cells with elongated nuclei and occasional nuclear grooves arranged in fascicles with admixed variably ectatic blood vessels. Nucleoli were inconspicuous, and the cytoplasm was scant, ill-defined, and pale/lightly eosinophilic. No sex cord component was present. Mitotic figures ranged from zero to five per 10 high-power fields. Significant atypia, lymphovascular invasion, and necrosis were absent. All were consistently positive for smooth muscle actin, S100 protein, FOXL2, and steroidogenic factor 1 but negative for h-caldesmon, calretinin, and SOX9. Inhibin and calponin were focally positive. All patients were alive and well at 5, 31, and 58 months postorchiectomy. Combining our cases with those previously reported (n = 6) shows that this neoplasm occurs mostly in younger men (mean, 37 years), and all follow-up thus far (mean, 25 months) has been benign.CONCLUSIONS: Myoid gonadal stromal tumors are small (<4 cm) indolent testicular tumors distinctly different from other sex cord-stromal tumors and are adequately managed by orchiectomy.

AB - OBJECTIVES: To report three new cases of testicular myoid gonadal stromal tumor to better characterize its features.METHODS: The clinicopathologic findings (including follow-up) were evaluated and a review of the literature was performed.RESULTS: The patients were 38, 43, and 59 years old, and tumor sizes were 1.2, 1.3, and 3.2 cm. All were unilateral, well circumscribed, adjacent to the rete testis, and composed exclusively of spindled cells with elongated nuclei and occasional nuclear grooves arranged in fascicles with admixed variably ectatic blood vessels. Nucleoli were inconspicuous, and the cytoplasm was scant, ill-defined, and pale/lightly eosinophilic. No sex cord component was present. Mitotic figures ranged from zero to five per 10 high-power fields. Significant atypia, lymphovascular invasion, and necrosis were absent. All were consistently positive for smooth muscle actin, S100 protein, FOXL2, and steroidogenic factor 1 but negative for h-caldesmon, calretinin, and SOX9. Inhibin and calponin were focally positive. All patients were alive and well at 5, 31, and 58 months postorchiectomy. Combining our cases with those previously reported (n = 6) shows that this neoplasm occurs mostly in younger men (mean, 37 years), and all follow-up thus far (mean, 25 months) has been benign.CONCLUSIONS: Myoid gonadal stromal tumors are small (<4 cm) indolent testicular tumors distinctly different from other sex cord-stromal tumors and are adequately managed by orchiectomy.

KW - Immunohistochemistry

KW - Myoid gonadal stromal tumor

KW - Testis

UR - http://www.scopus.com/inward/record.url?scp=84922232644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922232644&partnerID=8YFLogxK

U2 - 10.1309/AJCPGSCD1DGNZ0QO

DO - 10.1309/AJCPGSCD1DGNZ0QO

M3 - Article

VL - 142

SP - 675

EP - 682

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -